Evidence map›Paper›PMID 39840481›Full record

ArticleAdvanced healthcare materials2025

Universal Hydrogel Carrier Enhances Bone Graft Success: Preclinical and Clinical Evaluation.

Dax Calder, Farshad Oveissi, Simin Maleknia, Tom Huang, Bernard Koong, Terence Abrams, Andrew Oar, Wojciech Chrzanowski, Fariba Dehghani, Ali Fathi

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dax CalderSydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.
Farshad OveissiSchool of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia.ORCID 0000-0002-7464-8251
Simin MalekniaTetratherix Technology Pty Ltd, Sydney, NSW, 2000, Australia.
Tom HuangEnvision Medical Imaging, Wembley, WA, 6014, Australia.
Bernard KoongEnvision Medical Imaging, Wembley, WA, 6014, Australia.
Terence AbramsTetratherix Technology Pty Ltd, Sydney, NSW, 2000, Australia.
Andrew OarTetratherix Technology Pty Ltd, Sydney, NSW, 2000, Australia.
Wojciech ChrzanowskiSydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.
Fariba DehghaniSchool of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia.ORCID 0000-0002-7805-8101
Ali FathiSchool of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia.ORCID 0000-0002-9985-8992

Funding

Australian Government Research Training ProgramWenner-Gren Foundations
6 · The paper itself

Abstract

Orthopedic, maxillofacial, and complex dentoalveolar bone grafting procedures that require donor-site bone harvesting can be associated with post-surgical complications. There has been widespread adoption of exogenously sourced particulate bone graft materials (BGM) for bone regenerative procedures; however, the particulate nature of these materials may lead to compromised healing outcomes, mainly attributed to structural collapse of the BGM, prolonged tissue healing. In this study, a fully synthetic thermoresponsive hydrogel-based universal carrier matrix (TX) that forms flowable and shapable putties with different BGMs while spatially preserving the particles in a 3D scaffold at the implantation site is introduced. The potential synergistic effect of the carrier is investigated in combination with particulate demineralized bone matrix (DBM) in a standard muscle pouch nude mice model (n = 24) as well as in a rabbit femoral critical-sized cortico-cancellous bone defect model (n = 9). Finally, the clinical usability, safety, and efficacy of the carrier for the delivery of deproteinized bovine bone mineral (DBBM) are evaluated in a controlled clinical trial for extraction socket alveolar ridge preservation (ARP) (n = 11 participants). Overall, the TX carrier improved the delivery of different types of BGMs, maintaining these spatially at the implantation site with minimal inflammatory responses, resulting in favorable bone regenerative outcomes.

Indexed as

Bone TransplantationHydrogelsAdultAnimalsBone MatrixBone RegenerationBone SubstitutesCattleFemaleHumansMaleMiceMice, NudeMiddle AgedRabbitsTissue ScaffoldsBone SubstitutesHydrogelsbone graftbone healingplatform technologythermoresponsive hydrogeluniversal carrier

Identifiers

PMID39840481
PMCPMC12057595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.